Kevin Yu

Kevin Yu is an experienced marketing professional in the pharmaceutical industry, currently serving as the Associate Director of US Neuropsychiatry HCP Marketing at Biogen since August 2020, where significant accomplishments include the launch of ADUHELM under accelerated approval and the establishment of a commercial speakers bureau. Prior experience includes a role as Product Manager at Avanir Pharmaceuticals, where strategic development of NUEDEXTA marketing initiatives was led, and an Account Director position at RevHealth, where multiple product launches were successfully executed. Kevin's foundational experience in clinical trials was garnered while serving as a Clinical Affairs Research Fellow at Perrigo, managing Phase I - III trials and developing essential clinical documentation. Kevin holds a Doctor of Pharmacy degree from Rutgers University.